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CHAPTER 1. GENERAL INTRODUCTION 
Thesis organization 
This thesis is written in an alternative thesis format and contains three 
chapters: general introduction (Chapter 1 ), research paper (Chapters 2) and general 
discussion (Chapter 3). The general introduction includes a literature review 
concerning different techniques for cardiac output measurement. Chapter 2 is the 
article "Measurement of cardiac output by transesophageal Doppler ultrasonography 
in anesthetized dogs - comparison with thermodilution" which is to be submitted to 
the Journal Veterinary Anesthesia and Analgesia 
Introduction 
The primary role of the cardiovascular system is to maintain normal blood 
flow and oxygen delivery to the tissues. Together with the respiratory system, the 
cardiovascular system is the major determinant of oxygen tissue delivery. It is 
known that high-risk human surgical patients (e.g. septicemia, massive acute blood 
loss, acute renal failure or respiratory failure) are likely to develop inadequate tissue 
oxygen concentrations for two reasons: decreased oxygen delivery and/or increased 
oxygen consumption. A lack of tissue oxygen leads to tissue hypoxia which can 
trigger the cellular production of cytokines (e.g. tumor necrosis factor, interleukins, 
histamine and serotonin) that are thought to initiate or intensify organ failure. The 
resulting cellular hypoxia causes the metabolism to switch from aerobic to anaerobic 
with the production of lactic acidosis. Cell hypoxia and reperfusion injury can lead to 
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cell death and finally death of the patient. Therefore, it is essential to monitor and 
support the cardiovascular system of critically ill patients undergoing general 
anesthesia and surgery. 
The hemodynamic measurements frequently monitored in small animal 
veterinary clinics are: heart rate (HR), mean arterial blood pressure (ABP), 
electrocardiogram (ECG), arterial hemoglobin saturation with oxygen (Sp02) and 
central venous pressure (CVP). All of these parameters are useful but none of them 
directly evaluate tissue oxygenation. Although blood pH and lactate levels provide 
objective measurements to of inadequate tissue oxygenation they do not 
immediately reflect tissue hypoperfusion and tissue hypoxia. Identifying early 
undesirable hemodynamic changes are of tremendous importance for successful 
therapy. If adequate therapy is delayed until organ failure occurs the consequences 
are usually catastrophic. Therefore, in human critical care medicine and 
anesthesiology cardiac output (CO) measurement is an integral part of the 
preoperative, operative and postoperative care. 
Cardiac output is the product of stroke volume and HR and is an indicator of 
the heart's ability to pump blood to the peripheral tissues. A dynamic feature of the 
heart's function, the CO depends on the interrelationship of myocardial contractility, 
preload, afterload and HR. In critically ill patients it is likely that some of these 
factors are altered resulting in poor myocardial performance. Since the 
cardiovascular system is a closed system none of these four factors are totally 
independent and in combination they determine the CO. 
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Thermodilution (TD) is a clinically accepted technique for monitoring CO in 
human medicine. The balloon tipped TD catheter, properly placed in the pulmonary 
artery, not only allows measurement of CO, but also gives information about 
pulmonary artery occlusion pressure (PAWP) and CVP. However, benefit/risk ratio 
of the technique has been questioned. In veterinary medicine TD is not widely 
utilized in clinical monitoring due to invasive nature of the catheterization, 
requirement of a trained and experienced clinician and the cost. Therefore in 
veterinary medicine, TD is mainly used for research purposes while the clinical 
hemodynamic monitoring is primarily based on the HR, ABP, ECG, Sp02, and CVP. 
Transesophageal Doppler ultrasonography (TED) is one of the innovative 
techniques for CO monitoring. Although the equipment is expensive, it has potential 
use in veterinary medicine because it is non-invasive, gives real time and continuous 
data about cardiovascular function, and requires less expertise than TD. 
The purpose of this project was to examine the accuracy of the TED 
technique in dogs by comparing TED and TD CO measurements. The CO of 
experimental dogs was altered by applying different pharmacological and 
mechanical treatments. If the TED technique is accurate it offers significant 
advantages over TD and could be a very useful tool for anesthesia monitoring in 
high-risk veterinary patients. 
Background and significance 
The practice of anesthesiology involves providing support for critically ill 
patients undergoing surgery. This includes intensive and accurate monitoring of 
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parameters that might answer the most important question: are the tissues 
sufficiently oxygenated or not? Unfortunately, critically ill patients in almost all 
situations have significantly compromised pulmonary and cardiovascular function 
which anesthetic drugs may compromise even further. Therefore, monitoring these 
patients is crucial and one of the biggest challenges in veterinary anesthesia 
practice. An accurate and easy to use method to measure cardiac output would be 
extremely beneficial. 
In the early 70s, Shoemaker and colleagues described high-risk surgical 
human patients (e.g. septicemia, massive acute blood loss, acute renal failure, 
respiratory failure) that had postsurgical mortality rates between 30% and 40% 1. 
Research identified therapeutic goals that improved the survival of these patients. 
One treatment was to increase CO and therefore oxygen delivery (002) by the 
intravenous infusion of dopexamine hydrochloride which significantly reduced 
mortality and morbidity in the critically ill patients2. Increasing the 002 to at least 
600 ml/min per m2 resulted in a better prognosis and improved chances of survival. 
Williams and colleagues demonstrated that the oxygen (02) deficit was highest in 
the non-surviving patients, moderate in survivors with transient organ failure, and 
lowest in patients who survived with no organ failure3. Unfortunately, some 
pathological conditions alter not only the 002 to the peripheral tissues but also the 
0 2 utilization by the tissues. In septic shock patients severe tissue 0 2 deficits are 
due to impaired cardiovascular performance and increased metabolic rate4 . In this 
condition 0 2 demands are much higher than under normal physiological conditions. 
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The beneficial effect of improved CO and therefore 002 in septic patients was 
evident by the reduction in mortality from 74% to 40%. 
The 002 is the product of CO and arterial blood oxygen content (Ca02), 
which depends on respiratory and cardiovascular system coordination. The lungs 
must effectively take the 0 2 from the environment and move it into the blood while 
the cardiovascular system must provide sufficient flow of the oxygenated blood. The 
002 is determined by many parameters of which only seven can be altered in an 
attempt to improve 002: hemoglobin concentration (Hb), Sa02, HR, preload, 
myocardial contractility, mean arterial pressure (MAP) and total systemic vascular 
resistance (TSVR)5. 
Red blood cells contain hemoglobin which binds and carries 0 2 to the 
peripheral tissues. Since there is a very small amount of 0 2 dissolved in the blood, 
Ca02 mainly depends on the blood's Hb concentration because one gram of Hb 
binds 1.34 ml of 0 2. Furthermore, the Hb concentration can be easily determined 
and transfusion with a Hb containing solution will rapidly increase its concentration. 
The Sa02 is the percent of the Hb in the blood that is saturated with 02. The 
Sa02 can be measured by co-oximeters and estimated by the pulse oximetry or 
blood gas analyzer. It can be improved by increasing a patient's inspired oxygen 
concentration (Fi02), increasing alveolar ventilation, or reducing venous admixture. 
The HR together with stroke volume (SV) determines CO. Heart rate is easy 
to assess and can be pharmacologically manipulated if significant bradycardia or 
tachycardia occurs. 
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Cardiac preload is one of the three determinants of stroke volume6 . Preload 
determines the amount of stretch placed on the myocardial sarcomeres and is 
related to the quantity of blood that enters the ventricles during diastole (venous 
return to the heart) and ventricular compliance. Starling's law of the heart states that 
increased sarcomere stretch (increased blood volume in the ventricles) results in a 
more forceful contraction of the heart muscle to expel the increased volume. A 
decreased stretch results in the opposite effect6 . Since there is no clinically relevant 
method for determining sarcomere fiber length, clinicians rely on physical 
examination findings or pressure measurements to estimate preload such as central 
venous pressure and PAWP. Unfortunately, physical examination and pressure 
measurements can be unreliable indicators of intravascular volume6. 
Contractility is the ability of the heart to perform work (pump blood) and is 
entirely independent of preload and afterload. Parameters that are used as 
indicators of contractility are: ejection fraction (EF), peak velocity (PV) of blood flow 
in the aorta, acceleration (Ace) of the blood flow in the aorta, and dP/dt. Some of 
these indicators (e.g. EF, PV and Acc)7 can be estimated by echocardiography while 
others require cardiac catheterization (dP/dt). 
Afterload is the force opposing ejection of blood from the ventricles during 
systole. The MAP and TSVR are the two clinical measurements available to 
evaluate afterload. The MAP is the most common afterload parameter monitored in 
veterinary clinical practice. Although it reflects the peripheral force opposing ejection 
of the blood from the heart and the driving force for tissue perfusion, it is not a 
measure of tissue blood flow. In clinical situations of low CO, MAP could be close to 
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normal physiological values due to reflex sympathetic vasoconstriction. When the 
MAP is low, the clinician usually assumes that tissue blood flow and perfusion are 
compromised and tries to correct the hypotension (fluid therapy, vasopressor or 
inotrope therapy). 
Total systemic vascular resistance is also a component of the afterload. The 
TSVR can be calculated but it is not routinely applied in practice because the CO 
has to be measured. Although, TSVR can be very useful, there are situations in 
which TSVR is not equal to the afterload at all (e.g. patients with subaortic stenosis 
may have markedly increased afterload with normal or reduced TSVR). 
The CO is the amount of blood pumped from one ventricle per unit of time 
and represents the blood circulating throughout the body. Preload, afterload, and 
myocardial contractility are highly integrated in determining the CO of the heart. 
Separate monitoring of each of these three parameters would be very useful but still, 
none of them provide an accurate indication of adequate perfusion or 002. 
The CO measurement can be obtained by non-invasive and invasive 
methods. In the following pages we will describe basic characteristics of the most 
commonly used methods for the CO measurement. 
1. Invasive methods 
a) Thermodilution 
Swan and Ganz first introduced the pulmonary artery catheter (PAC) in the 
early 1970's8 for the measurement of CO by thermodilution. Today, PAC or Swan-
Ganz PAC is described as the clinically acceptable method for measuring CO in 
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human medicine9 . The Swan-Ganz catheter has an inflatable balloon, which 
enables it to be floated into the pulmonary artery through the right side of the heart, 
using the natural flow of the blood. Shortly after the original catheter was introduced 
into clinical practice, a thermistor was added, which allowed CO to be measured by 
thermodilution (TD). A thermal indicator (e.g. cold saline or 5% dextrose) of a known 
temperature is injected in the right atrium (proximal port of the catheter) and the 
resultant change in the temperature of the pulmonary artery blood is continuously 
recorded by a thermal sensor (termistor) mounted at the tip of the catheter5 . The 
computer uses different parameters obtained during recording to calculate the CO 
according to the following formula 10: 
COro =Vi * ri *Ci (Tb-Ti)* 0.825 * 60 I rb * Cb* J DTb(t)dt 
CO - cardiac output (I/min); Vi - injectate volume (ml); Ti - injectate temperature 
(C); DTb - the temperature of blood injectate mixture at the distal thermistor; rx and 
Cx are the specific gravity and heat of the blood (B) and injectate (I) respectively; 60 
= 60 s/min; 0.825 = empirical correction factor for catheter warming. The expression 
(ri * Ci I rb * Cb) is a constant that is related to the type of injectate. For 5% dextrose 
it is equal to 1.08 and for saline it is equal to 1.0. The expression ( DTb(t)dt) equals 
the area under the temperature vs time curve and is the mean indicator of 
temperature change over time. 
It has been shown that thermodilution correlates well with two other methods 
of CO measuring: Fick's method and indicator dye dilution method1 . Besides the 
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CO, PAC provides other valuable measurements such is CVP and PAWP12. When 
a pressure transducer is connected to the proximal port of the catheter located in the 
right atrium the CVP can be measured. By inflating the balloon in the pulmonary 
artery a wedge pressure can be obtained which estimates the left atrial pressure. 
Both of these parameters may provide insight into the vascular volume status of the 
patient and help in making decisions about fluid therapy. However, there are 
controversial reports about safety and accuracy of the Swan-Ganz catheter. Some 
groups reported a low incidence of morbidity and/or mortality associated with the 
PAC and a low risk-benefit ratio12·13·. On the contrary, there are many authors who 
are concerned about the complications associated with the catheter and have 
published risk-benefit analysis that revealed an increased morbidity and mortality in 
the patients 14•15•16·17. When the facts of an unclear risk-benefit ratio, the 
invasiveness of PAC placement, and the intermittent CO measurements are taken 
into consideration, it is not surprising that several new technologies are being 
proposed. 
b) Fick oxygen method 
The Fick's principle, applied to the CO measurement, states that the amount 
of 0 2 uptake by an organ (02 consumption) depends on the blood flow (CO) to that 
organ and arteriovenous 0 2 concentration difference 10. To measure the global CO, 
the 0 2 consumption is measured as the difference of the 02 concentration in the 
inspired and expired air18. The arterial 0 2 concentration is measured from the 
peripheral artery blood sample and venous 02 concentration is measured from the 
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mixed venous blood sample obtained from the PA catheter19. By calculating the 
ratio between oxygen consumption and the arteriovenous oxygen difference, the CO 
can be determined as shown in the formula 10: 
Cardiac output (I/min) = Oxygen consumption (ml 02/min) I 
Arteriovenus oxygen difference (ml 0 2/1 blood) 
It has been shown that Fick's method correlates well with thermodilution in 
dogs (r2=0.97)20 but due to the technical demands and invasive nature of the 
procedure it is not widely accepted in veterinary medicine 10. 
c) Indicator dilution method 
This CO measurement technique is based on the injection of an indicator of a 
known concentration in the right atrium or right ventricle and subsequent 
measurement of the concentration of the same indicator in the peripheral circulation 
(usually femoral artery) by an optical detector (densitometer)18. The dilution of the 
indicator in the peripheral circulation depends on the blood flow (CO). It has been 
shown that the dye dilution method correlates well with thermodilution and the Fick 
method for CO measurement2° but it has been used mostly for research purposes 
because it is technically difficult, time consuming, and requires frequent blood 
sampling. 
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d) Lithium dilution method 
Lithium dilution method is another type of dilution method which has been 
validated in the past 10 years21 . This method is based on the use of lithium as an 
alternative indicator for the CO measurement. Briefly, isotonic lithium-chloride, in a 
small dose (0.002-0.004 mM/kg) that does not have any pharmacological effect, is 
injected as a bolus in the right atrium or right ventricle. A change of the ion 
concentration is monitored by an ion-sensitive electrode attached to the arterial line 
manometer system in the periphery 21 . Since lithium chloride concentration highly 
depends upon sodium and Hb concentration, these two parameters have to be 
independently measured and delivered to the computer for the precise estimation of 
the C021 . It has been reported that the lithium dilution method can be a suitable 
method for CO measurement in dogs22. 
Invasive methods for the monitoring of CO are reliable. But necessitate 
cardiac catheterization carries a risk of eventual development of cardiac arrhythmia, 
damage to the endothel ium of blood vessels, and subsequent thrombosis. Due to 
these reasons, it was important to develop devices and techniques, which would be 
reliable and non-invasive to determine the CO. 
2. Non-invasive methods 
Ultrasound monitoring methods have become an important area of research 
because they are non-invasive and safe. Ultrasound monitoring techniques are 
based on the Doppler effect23. The Doppler effect is a change in ultrasound wave 
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frequency as the ultrasound wave is being reflected from a moving target. If the 
motion is toward the transducer, the frequency of the returning echo is higher than 
that of the transmitted ultrasound beam. If the motion is away from the transducer, 
the echoes have a lower frequency than the transmitted ultrasound beam. The 
difference between the transmitted and received frequencies is a Doppler shift. 
This is the basic principle behind all Doppler techniques for the measurement of CO 
regardless of the type of machine or position of the probe. The most frequently 
employed non-invasive monitoring techniques, which use the Doppler principle, are 
the transesophageal and transthoracic approaches7. 
a) Transesophagealapproach 
Transesophageal Doppler measurement of CO can be made from the left ventricular 
outflow tract, aortic valve, mitral valve, main pulmonary artery or the right ventricular 
outflow tract24and descending aorta25·26•27•28 . Although , these techniques are not 
invasive, the accuracy has been questioned9•29•30•31 •32 . The most frequently used 
approach is the measurement of the CO from the descending aorta. 
In 1975 Diagle et al. proposed a new method for CO monitoring where 
ultrasound transducer was incorporated in the esophageal probe33 . Initially, the 
esophageal probe only had a Doppler ultrasound transducer incorporated which 
measured blood velocity in the descending aorta. The device did not measure the 
descending aortic diameter which was estimated using nomogram (a nomogram is 
the table of estimated values of the aortic diameter which is calculated by comparing 
patients weight, height, age and postmortem aortic diameter). It has been 
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suggested that these nomograms could be a potential error source in CO 
measurement 29•30. 
One of the most recent transesophageal Doppler (TED) CO monitoring 
devices is the Hemosonic 100™ (Arrow International). It measures blood velocity in 
the descending aorta by using a 5 MHz Doppler transducer and records descending 
aortic diameter by using an M-mode ultrasound transducer. 
The transesophageal probe is a 20 French, 60 cm long flexible shaft. The 
probe is covered with an ultrasound transparent jacket filled with acoustic gel. The 
jacket protects the probe, ensures the proper transmission of the ultrasound to the 
tissues, and avoids esophageal mucosa! injury caused by the rotation of the probe. 
An articulated arm is attached to the surgery table and holds the probe in its proper 
position. Two ultrasound transducers are located towards the end of the probe, and 
adjacent to the 5 cm long flexible silicone tip. Aortic blood velocity is measured with 
the pulsed Doppler ultrasound transducer which is at the same time the receiver. 
The probe has a rotatable inner part attached to the transducers and an outer part 
that is fixed. By using the probe handle the inner part can be rotated to position the 
transducers without moving the outer part or the jacket. 
The echo-Doppler screen displays blood velocity from the Doppler 
transducer and the M-mode aortic tracing. It guides the user in obtaining the optimal 
probe position. The monitoring screen displays hemodynamic parameters of the 
patient. 
Aortic diameter is measured by the M-mode transducer. The emitted 
ultrasound beam is perpendicular to the central probe axis. Because of the incident 
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beam is high collimation, choice of 10 MHz frequency, and size of the receiver; 
angular scattering from the aorta occurs in a very narrow spatial angle. If the probe 
and the aorta are correctly aligned (parallel to each other) the reflected ultrasound 
beam from the proximal and distal walls are detected by the receiver. When the 
incident beam is directed obliquely across the aorta only the signal reflected from the 
proximal aortic wall is detected by the receiver34 . 
The pulsed Doppler ultrasound transducer measures the blood velocity in the 
descending aorta using a 5 MHz widely planar beam that bisects the aorta at a 60 
degree angle. The device measures the Doppler frequency shift produced by the 
moving blood cells and converts it onto the spatially averaged blood velocity in the 
entire aortic cross section. The ultrasound beam "range gated" to improve the 
accuracy of the received signal34 . 
Besides ABF and CO the machine also provides numerical information about: 
PV, Ace, left ventricular ejection time (LVETi} and TSVR35. The HemoSonic100™ 
might be a promising device that could be used on everyday basis in human critical 
care medicine as well as in veterinary critical care medicine and anesthesia. It is a 
nontraumatic technique that provides continuous, real time hemodynamic 
monitoring. Since it also measures or calculates preload, afterload and contractility 
parameters it provides the clinician with to rapidly interpret and precisely manage 
changes in the blood flow. 
In the past few years, the research of esophageal Doppler systems has been 
intensified, especially in human medicine where the CO monitoring is integral part of 
intensive care medicine. Transesophageal Doppler (TED) recordings were usually 
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performed simultaneously with TD measurements. Although there are reports which 
indicated a high correlation between the two methods36·37 , other studies did not29•30 . 
A low correlation has been reported in certain surgical procedures such as aortic 
reconstructive surgery39 , cardiac surgery38 or liver transplantation surgery30 . There 
have been also reports that some pharmacological interventions, like epidural pain 
management, might interfere with the accuracy of the ultrasound monitoring 
procedure40 leading to a low correlation between TD and TED. 
The TED has not been extensively examined for veterinary purposes. 
Wong at al. (1991) reported that TED correlated poor with TD after changes in 
preload, afterload and contractility in pigs29 . Young al. reported that after 
dopexamine hydrochloride infusion in the horses, the Doppler signal was not 
adequate and the authors hypothesized that lack of the quality in Doppler signal , 
might be responsible for the inaccurate CO measurements27 . 
While TD has not been accepted in veterinary medicine as a standard 
procedure due to the relatively high cost of the equipment, invasive nature of 
procedure and personal training requirements, the non-invasive Doppler techniques 
might offer less complicated and still reliable methods for CO estimation in critical 
care veterinary medicine and anesthesiology. 
b) Transthoracic approach 
While literature data implicated high correlation between transthoracic 
ultrasound techniques and invasive methods25 , the major disadvantages of this 
method are the high cost of the equipment, a need for competent and trained 
16 
personnel and relatively slow data acquisition since the proper positioning of the 
probe is essential for the reliable readings of the CO. These disadvantages are 
major limiting factors for the use of this technique, especially during emergency and 
surgical conditions where information has to be obtained fast and accurate. 
While different methods have been described for measurement of CO, it is 
not clear which particular method would be the most suitable for the clinical use in 
veterinary medicine. The major advantage of the invasive methods is accuracy in 
the estimation of the cardiac output. However, the invasive nature of the procedure, 
is the major limiting factor for the widespread use of these methods. Doppler based 
ultrasound machines are characterized by non-invasiveness and relatively good 
accuracy in CO measurement in human patients. While these machines, are 
primarily designed and adjusted to the human anatomical and physiological 
characteristics, they might be effective tools for the evaluation of animal patients 
during critical conditions. Due to the anatomical differences between human and 
veterinary patients it is essential to thoroughly investigate, whether these techniques 
can be reliably used in different animal species. 
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CHAPTER 2. MEASUREMENT OF CARDIAC OUTPUT BY 
TRANSESOPHAGEAL DOPPLER UL TRASONOGRAPHY IN ANESTHETIZED 
DOGS - COMPARISON WITH THERMODILUTION 
A paper to be submitted to Veterinary Anesthesia and Analgesia 
Tatjana Lazic, Dean H. Riedesel and Richard Evans 
Abstract 
Objective: To compare cardiac outputs (CO) measured by a transesophageal 
Doppler ultrasound technique (TED, Hemosonic 100™, Arrow Int) and CO measured 
by thermodilution (TD) in anesthetized dogs. 
Design: lnterventional studies 
Settings: Veterinary Teaching Laboratory- Iowa State University 
Animals: The study included 10 canines weighing from18.5 kg to 32.5 kg. Set 
criteria for inclusion were adequate body size of the dogs for placement of the 
esophageal probe (body weight >18.5 kg) and stable anesthesia maintenance 
period. 
Interventions: Simultaneous TED and TD measurements of CO were obtained 
during initial baseline period. The baseline CO was then altered by constant rate 
intravenous infusion of dobutamine, dopamine and norepinephrine; and by caudal 
vena cava occlusion. 
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Results: Each measurement of CO allowed a comparison of TED and TD values. 
Forty-nine CO paired comparisons were made with the CO ranging from 0.73 I/min 
to 10.9 I/min (obtained by TD). Simple linear regression was used to determine the 
correlation between the two techniques (r2=0.53). Bland and Altman statistical 
method was used for assessing agreement between the two methods. The 
difference between the TD and TED was 0.82 I/min (bias) and SD was 1.63 I/min. At 
baseline and low CO levels (caudal vena cava occlusion) the correlation coefficient 
(r2) was 0.77 and at high CO levels (dobutamine, dopamine and norepinephrine 
infusions) the correlation coefficient (r2) was 0.45. 
Conclusion: The TED might be a useful method for detecting low CO trends and 
aid in determining the cause of hypotension. 
Keywords: cardiac output, Doppler ultrasound, thermodilution, dog. 
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INTRODUCTION: 
The practice of anesthesiology involves providing support for critically ill 
patients undergoing surgery. This requires accurate monitoring of parameters which 
are capable of predicting oxygen delivery to the tissues. Unfortunately, critically ill 
patients in almost all situations have significantly compromised pulmonary and 
cardiovascular function which anesthetic drugs may compromise even further. 
Therefore, monitoring these patients is a crucial goal and one of the biggest 
challenges in veterinary anesthesia practice. An accurate, non-invasive method for 
measuring cardiac output (CO) would be extremely beneficial for the proper 
evaluation of the cardiovascular function in critically ill patients. 
In human medicine, CO monitoring has become an integral part of 
cardiovascular monitoring in critically ill patients undergoing general anesthesia. 
Thermodilution (TD) is the most commonly employed method of CO monitoring but, 
there are some well recognized limitations regarding the use of the technique: 1) 
pulmonary artery catheterization requires time and participation of experienced 
personnel to position the catheter1, 2) it provides only intermittent hemodynamic 
information, 3) data could be misinterpreted2, 4) the cost is not negligible, and 5) TD 
has been associated with increased mortality or morbidity3.4·5. In veterinary medicine 
TD is rarely used in clinical settings because of its invasive nature and cost and it 
has been manly used in the research purposes6·7. 
Transesophageal Doppler ultrasonography (TED) is a minimally invasive 
technique for measuring blood flow in the descending aorta based on the Doppler 
effect8 . The Doppler effect is based on a change in frequency or wave length of 
26 
ultrasound caused by the motion of a wave source, receiver, or reflector. In the case 
where the CO is to be determined, the moving objects are blood elements. 
Ultrasound waves are reflected with a different wave length from the moving blood 
cells. This change in frequency or wave length is used to calculate the velocity of 
blood flow and is basic principle behind all Doppler techniques for the measurement 
of CO regardless of the type of machine or position of the probe. The TED, with the 
advantage of being relatively easy to perform and continuous CO monitor might offer 
an alternative to TD9·10·11 . 
Recently, Arrow International has marketed in Europe and North America an 
TED ultrasound based system for monitoring CO (Hemosonic 100 ™). 
The purpose of this study was to compare CO values obtained by TED with 
those obtained by TD in anesthetized dogs and evaluate the potential usefulness of 
TED for obtaining CO measurements during conditions characterized by low or high 
CO values. 
MATERIALS AND METHODS: 
All animal studies were conducted in accordance with the Guiding Principles 
in the Care and Use of Animals (DHEW Publication, NIH 80-23) and procedures 
were approved by the Iowa State University Committee on Animal Care. Ten mixed 
breed dogs were used in the study. All dogs were given a preanesthetic medication 
of acepromazine (0.1 mg/kg, IM). Anesthetic induction was accomplished by use of 
thiopental (10 mg/kg, IV) and maintenance with isoflurane. End-tidal isoflurane and 
carbon dioxide (C02) concentrations were maintained at 1.3% and 35-45 mmHg, 
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respectively. Eight of the ten dogs were studied following a veterinary student 
surgical laboratory. 
Instrumentation and monitoring 
Systolic, diastolic and mean blood pressures were monitored by catheterizing 
the dorsal metatarsal artery. The arterial catheter was connected to a pressure 
transducer (Tru Wave,Baxter) and monitor (Passport, Datascope corporation). An 
electrocardiogram (ECG) was used to assess heart rate (HR) and rhythm. Pulse 
oximetry was used to measure pulse rate and arterial hemoglobin oxygen saturation. 
A capnometer was used for measuring end-expiratory and inspiratory C02 
concentrations. Normocapnia (end-tidal C02 from 35 to 45 mmHg) was maintained 
by mechanical ventilation (Hallowell engineering, manufacturing corporation). Body 
temperature was maintained between 95-100 F with circulating warm water pads 
(Gaymar) and forced warm air (Bair Hugger, Augustin). A 6 French, 80 cm, balloon 
tipped occlusion catheter (Fogarty, Edwards Lifesciences) was inserted through the 
femoral vein and advanced to the thoracic portion of the caudal vena cava. The 
balloon was inflated with air to produce caudal vena cava occlusion. A 7 French, 4 
lumen, 110 cm balloon tipped thermodilution catheter (Arrow International) was 
inserted through the jugular vein and advanced to the level of the pulmonary artery 
(guided by pressure wave analysis). 
The TED probe was covered with a disposable gel filled sheath Uacket), 
lubricated, and inserted into the esophagus to the level of the seventh or eighth 
intercostal space. The probe was then rotated until the best echo and Doppler 
signals were found . The probe insertion depth and orientation were checked before 
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each recording of data such that both the proximal and distal aortic walls were 
visualized (with maximum aortic diameter) and an appropriate velocity curve from 
the pulsed Doppler transducer appeared on the monitor. 
Measurement of CO 
The TD CO measurement procedure was performed by injecting 5 cc of cold 
5% dextrose in water through the proximal port (right atrium) of the pulmonary artery 
catheter in the right atrium. The catheter's thermistor was connected to a computer 
(COM-2, Baxter Healthcare corporation) which converted the resultant blood 
temperature change into the CO. Syringes were prefilled with 5% dextrose and kept 
in an ice bath for at least 6 hours prior to each procedure. All TD measurements 
were performed at the end of expiration by arresting the ventilator. Each TD CO 
measurement was an average of 3 consecutive values which were obtained with a 
difference less than 10%. The mean of TD CO measurements were used for 
comparison with the mean of three simultaneously obtained TED measurements. 
Experimental protocol: 
During the initial baseline period no pharmacological or mechanical 
interventions were made. The CO was than altered by randomly administering the 
following treatments: dobutamine (10 µg/kg/min), dopamine (10 µg/kg/min), 
norepinephrine (10 µg/kg/min), and caudal vena cava (CVC) occlusion. The 
basel ine CO was always performed at the beginning of each experiment followed by 
the treatments administered randomly to each dog. No attempt was made to ensure 
that the CO was identical for each treatment for each dog. Measurements were only 
obtained when the dogs were hemodynamicaly stable following application of the 
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treatment. Each treatment was continued for at least 10 minutes to achieve stable 
CO values12. Hemodynamic and respiratory variables were recorded to document 
stability during the data collection. 
Transesophageal Doppler monitoring system description 
The Hemosonic 100™ (Arrow International) consists of a main console, 
connection cable, transesophageal probe, probe jacket and articulated arm with the 
probe holder. The main console contains electrical hardware, control keys, and 
connectors. Three screens may be displayed on the main console. The first screen 
displays instructions for the user. The second is echo-Doppler screen which 
displays blood velocity from the Doppler transducer and the M-mode aortic tracing. 
It guides the user in obtaining the optimal probe position. The third monitoring 
screen displays hemodynamic parameters of the patient. A connection cable is 
used to attach the probe to the main console. The transesophageal probe is a 20 
French, 60 cm long flexible shaft which is covered with an ultrasound transparent 
jacket filled with acoustic gel. The jacket protects the probe, ensures the proper 
transmission of the ultrasound to the tissues, and avoids esophageal mucosa! injury 
caused by the rotation of the probe. The articulated arm is attached to the surgery 
table and holds the probe in its proper position. Two ultrasound transducers are 
located towards the end of the probe (Fig.1) and adjacent to the 5 cm long flexible 
silicone tip. Aortic diameter is measured by an M-mode transducer and the aortic 
blood velocity is measured with a pulsed Doppler ultrasound transducer. The probe 
has an inner part where the transducers are located and outer part that is fixed. By 
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using the probe handle the inner part can be rotated to position the transducers 
without moving the outer part or the jacket. 
Measurements of diameter and blood velocity in the descending aorta 
The M-mode ultrasound transducer was used to measure the descending 
aortic diameter. The emitted ultrasound beam is perpendicular to the central probe 
axis. Because of the incident beam's high collimation, 10 MHz frequency, and size 
of the receiver, angular scattering from the aorta occurs in a very narrow spatial 
angle. When the probe and the aorta are correctly aligned (parallel to each other) 
the reflected ultrasound beam from the proximal and distal walls are detected by the 
receiver (Fig.2A). If the incident beam is directed obliquely across the aorta (Fig. 
28) only the signal reflected from the proximal aortic wall is detected by the 
receiver13. 
The pulsed Doppler ultrasound transducer measures the blood velocity in the 
descending aorta. It produces a 5 MHz widely planar beam that bisects the aorta at 
a 60 degree angle. The device measures the Doppler frequency shift produced by 
the moving blood cells which provides a measurement of the spatially averaged 
blood velocity in the entire aortic cross section (Fig. 1) and gates the range of the 
received signal13. 
STATISTICAL ANALYSES 
Correlation between the two techniques was determined using simple linear 
regression analysis. A p value smaller than 0.05 was considered statistically 
significant. Simple linear regression was also performed separately with data 
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obtained during the baseline and vena cava occlusion periods (referred to as low CO 
levels) and dobutamine, dopamine and norepinephrine infusion periods (referred to 
as high CO levels). Bland and Altman analysis was used to assess agreement and 
explore for systematic and random errors. The bias (mean difference) represents 
the systematic error between the two methods. The SD of the bias represents the 
random error or variability between the different methods. Mean difference +/- 2SD 
is known as the "limits of agreement". Since all dogs underwent more than one CO 
measurement the variations between two time points in TD and TED were compared 
using two way analysis of variance (ANOVA) for repeated measurement with Tukey-
Kremor post-test analysis to confirm that the difference between baseline level and 
other 4 levels was statistically significant. 
RESULTS 
The TD and TED CO pairs were compared in each dog and treatment. A 
total of fifty CO paired comparisons were possible. After exclusion of one CO pair 
during dobutamine infusion in one dog (marked tachycardia), forty nine CO paired 
observations were used for the statistical analyses. There were ten baseline, nine 
dobutamine, ten dopamine, ten norepinephrine and ten caudal vena cava occlusion 
measurements. The mean values +/- SEM for all five CO levels measured by TD 
and TED are presented in table 1. Transesophageal probe placement was easily 
accomplished in each dog. An adequate M-mode and Doppler signals were found 
within a few minutes. Cardiac output ranged from 0. 73 I/min to 10.9 I/min when 
measured using TD, and from 1.25 to 6 I/min when measured by TED. A significant 
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correlation between TED and TD measurements was present during the baseline 
and caudal vena cava occlusion levels (n=20, r2-=0.77, p< .0001, Fig. 3A). A 
significant correlation was no longer present during dobutamine, dopamine and 
norepinephrine interventions (n=29, r2-=0.45, p<.0001 , Fig. 3B). In addition, when all 
measurements were included the correlation was not significant (n=49, r2-=0.53, p< 
.0001, Fig 3C). 
The Bland-Altman analysis included all data. The mean difference 
between TD and TED measurements (bias) was 0.82 I/min, 1 SD was 1.63 I/min and 
the limit of agreement was -2.44 to 4.08 I/min (Fig. 4). The ANOVA for repeated 
measurements with Tukey-Kremor post-test analysis confirmed significant difference 
between baseline versus dobutamine (p<0.001 ), dopamine (p<0.01) and 
norepinephrine (p<0.05) CO levels. In addition, the same test confirmed a 
significant difference between caudal vena cava occlusion vs the previous treatment 
values (p< 0.001 ). 
DISCUSSION 
The statistical analysis revealed a significant increase in the CO when 
positive inotropic agents were used and a significant decrease of the CO with CVC 
occlusion. There was a weak correlation between TED and TD techniques when 
dobutamine, dopamine and norepinephrine were used (r2-=0.45). When the CVC 
occlusion was used to decrease CO, the correlation between two the techniques 
was reasonably good (r2-=0. 77). However, when all paired data were combined the 
general correlation analysis coefficient was weak (r2-=0.53). The Bland and Altman 
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analysis revealed that the systemic error (bias) between two techniques was 0.82 
I/min. This indicate that TED measurements can differ from TD measurements for 
0.82 I/min at any time. Since the Hemosonic 1 OOTM was calibrated to calculate CO 
from the ABF in the descending aorta in humans, it is possible that this has 
influenced the magnitude of the bias. However 1 SD was large (1 .63 I/min) and 
limits of agreement were large ranging from - 2.44 I/min to 4.08 I/min. Observing the 
Bland-Altman plot, there is an obvious increase in scattering as the CO increases 
indicating that there is a less agreement between two techniques in higher CO 
levels. Previously published data regarding the accuracy of CO measurements 
obtained by TED are conflicting. Wong and colleagues 14 used transient time 
ultrasound (TTU) as a reference method in pigs. The agreement between TED and 
TTU was good in the decreased preload group induced by bleeding, however weak 
agreement was observed between the two techniques in the increased contractility 
group when dobutamine infusion was used. In the study where various degrees of 
cardiac tamponade in pigs were used to decrease CO, the correlation between TD 
and TED was high (r2=0.89)9 . A study on humans receiving liver transplants 
revealed an inconsistent difference between TD and TED15. However, other studies 
on human patients observed a good correlation between the two techniques when 
dobutamine 10·16and fluid therapy 17 were used. Young and colleagues reported18 
reported that tranesophageal echocardiography can provide an alternative for TD in 
anesthetized horses. 
The assessment of CO by TED offers several advantages over TD but the 
determination of CO by the Hemosonic100 TM is based on several assumptions which 
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may cause inaccuracies. The first assumption is that the aorta and esophageal 
probe are positioned nearby and parallel to each other. The Hemosonic 100 TM uses 
the M-mode ultrasound imaging of the aortic walls and clear visualization of the 
proximal and distal aortic walls on the monitoring screen is the confirmation of 
proper probe positioning. During this study, the probe was repositioned prior to each 
CO measurement, in an attempt to improve the M-mode signal. A computed 
tomography scan of one dog with the TED probe properly positioned revealed that 
the probe was nearby desired parallel to the aorta (Fig 5). In humans a satisfactory 
M-mode signal is usually obtained when the transducer is positioned at the level of 
the third intercostal space. In this study, the best M-mode signal was obtained when 
the transducer was positioned at the level of the seventh intercostal space. The 
exact position of the probe was confirmed on postmortem examination of three dogs. 
The second assumption is that the blood flow in the descending aorta is 
laminar since the Doppler transducer averages the blood velocity over the entire 
cross section during the ejection phase. It's not known whether positive inotropic 
drugs induce turbulent blood flow in dogs. However, an irregular shape of the 
Doppler signals in this study (Fig 6) closely resembles changes observed in dogs 
where methoxamine caused turbulent blood flow19. In addition, during dobutamine, 
dopamine and norepinephrine infusions, the down-stroke of Doppler velocity trace 
became notched in the most dogs. Young and colleagues have reported the similar 
finding in horses during dopexamine hydrochloride infusions 20. 
The third assumption is that the distribution of ascending aortic blood flow 
remains always the same since CO is calculated from the ABF under assumption 
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that 70% of CO is distributed in the descending aorta and 30% of CO is distributed in 
the brachiocephalic trunk and left subclavian artery. However, it has been reported 
that under the sympathetic and vagal stimpulation in dogs this ratio changes21 . In 
addition, the study where the different cathecholamines were used in dogs, CO 
distribution ratio was also changed22. 
CONCLUSION 
The TED as a method for CO measurement that may have value in canine 
patients with compromised cardiovascular parameters and decreased CO. This 
study demonstrated that TED has a reasonably good correlation with TD during low 
CO conditions and it is hypothesize that TED might be a useful non-invasive 
monitoring technique in similar clinical conditions. However, in situations, where 
blood flow might have turbulent characteristics, the validity and accuracy of this 
method does not appear to be sufficient for clinical use in dogs. 
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Figure 1. The pulsed Doppler ultrasound transducer measures the blood velocity in 
the descending aorta with the 5 MHz widely planar beam that bisects the aorta at a 
60 degree angle. The M-mode transducer measures descending aortic diameter 
using 10 MHz, highly collimated beam. 
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Figure 2. A) The incident beam is directed obliquely across the aorta and only the 
signal reflected from the proximal aortic wall is detected by the receiver. B) If the 
probe and the aorta are correctly aligned (parallel to each other) the reflected 
ultrasound beam from both the proximal and distal walls are detected by the 
receiver7. 
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Figure 3. A) Significant correlation between TED and TD measurements was 
present during the baseline and caudal vena cava occlusion levels (n=20, r2=0.77 , 
p< .0001 ). B) The significant correlation was no longer present during dobutamine, 
dopamine and norepinephrine interventions (n=29, r2=0.45, p<.0001 ). C) The 
correlation was not significant for all measurements (n=49, r2=0.53, p< .0001, Fig 
3c). 
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Figure 4. The Bland-Altman analysis. The mean difference between TD and TED 
measurements (bias) was 0.82 I/min, 1 SD was 1.63 I/min and the limit of agreement 
was - 2.44 to 4.08 I/min 
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PROBE AORTA 
Figure 5. A computed tomography scan of an anesthetized dorsally recumbent dog 
showing the TED probe positioned nearby and parallel to the aorta while baseline 
recordings are being made. 
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Baseline 
Dobutamine 
Figure 6. The irregular shape of Doppler signals was detected when positive 
inotropes (in this picture - dobutamine) were used. 
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TD (I/min) TED (I/min) 
Baseline (mean±SEM) 2.73±0.38 2.43±0.25 
Dobutamine (mean±SEM) 5.52±0.92 *** 3.13±0.26 
Dopamine (mean±SEM) 4. 73±0.54 ** 3.59±0.31 
Norepinephrine (mean±SEM) 4.39±0.49 * 2.91±0.27 
eve occlusion (mean±SEM) 1.58±0.25 +++ 2.12±0.21 
Table 1. The mean values +/- SEM for all tested CO levels measured by TD and 
TED and ANOVA for repeated measurements results. Values significantly different 
from baseline-*** (p<0.001 ), ** (p<0.01 ), * (p<0.05). Values significantly different 
from the previous treatment- +++ (p< 0.001 ). 
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CHAPTER 3. GENERAL CONCLUSIONS 
General discussion 
The purpose of this study was to compare CO values obtained by TED with 
CO values obtained by TD in healthy dogs and evaluate potential usefulness of the 
TED as a non-invasive method for CO measurements during low and high CO 
conditions. 
While different methods have been described for CO measurement it is still 
not clear which particular method would be the most suitable for frequent use in 
veterinary medicine. The major advantage of invasive methods is accuracy in the 
estimation of the CO. However, the invasive nature of the procedure is the major 
limiting factor for the widespread use of these methods. The Doppler based 
ultrasound machines are characterized by non-invasiveness and good accuracy in 
the measurement of CO in human patients. Due to anatomical differences between 
human and veterinary patients, this project was designated to investigate, whether 
TED can be reliably used in dogs. 
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Ten healthy dogs were used in the experiment. Each dog received a random 
application of treatments to alter CO values. Dobutamine, dopamine and 
norepinephrine were used as positive inotropic agents to increase CO, while CVC 
occlusion was used to decrease venous return to the heart and subsequently 
decrease CO. 
Cardiac output in our study ranged from 0. 73 I/min to 10.9 I/min when 
measured using thermodilution , and from 1.25 to 6 I/min when measured by TED. 
Significant correlation between TED and TD measurements was present during the 
baseline and caudal vena cava occlusion levels (n=20, r=0.77, p< .0001 ). However, 
the correlation was no longer significant during dobutamine, dopamine and 
norepinephrine interventions (n=29, r=0.45, p<.0001 ). When all paired data were 
combined the general correlation analysis coefficient was weak (r2=0.53). 
This study demonstrated that TED has a reasonably good correlation with TD 
during low CO conditions and it is hypothesized that TED might be a useful non-
invasive monitoring technique in similar clinical conditions. However, in situations, 
where blood flow might have turbulent characteristics, the validity and accuracy of 
this method does not appear to be sufficient for the regular clinical use in dogs. 
Further directions 
This experiment revealed a potential for the use of TED for CO monitoring in healthy 
dogs with experimentally induced low CO. To validate the utility of the method, it 
would be essential to perform recordings in real patients who suffer from serious 
malfunction of the cardiovascular and/or respiratory system. Furthermore, it would 
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be very important to correlate outcome of therapeutic strategies in critical patients 
whose therapy was guided by TED parameters and compare survival rate with 
patients which received therapy without precise estimation of the CO values. The 
validity and justification of the method can be achieved only when a cohort of 
patients is analyzed and benefit of the procedure is proved. Until that kind of 
evidence is available, the recommendation for the frequent use of TED in veterinary 
anesthesia and critical care can not be given. 
49 
ACKNOWLEDGEMENTS 
I would like to express my sincere gratitude to my major professor, Dr Dean 
Riedesel. Without his guidance, help and patience, I would have never met my goal. 
I would also like to thank to other members of my committee, Dr Christopher 
Brown and Dr loana Sonea for enormous moral support during my study. 
A special thanks goes to Arrow International company for providing 
equipment and technical support which was essential for the performance of my 
experiment. 
My thanks extend to the Department of Veterinary Clinical Sciences for 
providing space as well as additional equipment for my experiments. 
Finally, I would like to express my deep appreciation to my family for their 
patience, love and support. 
